Prawo i regulacje · 20/08/2012

Lipomed Seeks FDA Approval for New Medication, Becomes Latest Company to Apply for Controlled Substance Importation Permit

Lipomed, a pharmaceutical company, has submitted a notice of application to the FDA for an importer of controlled substances permit, marking the company's latest move in the regulatory process for its new medication